The deal priced at last closing price of $4.03. Jefferies, Leerink and William Blair are acting as joint book running managers for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLDB:
- Solid Biosciences reports initial clinical data from INSPIRE DUCHENNE trial
- Biotech Alert: Searches spiking for these stocks today
- Analysts Predict Up to ~450% Surge for These 2 ‘Strong Buy’ Penny Stocks
- Positive Outlook for Solid Biosciences: Anticipated Trial Data and Gene Therapy Platform Drive Buy Rating
- Solid Biosciences reports inducement grants under Nasdaq listing rule